Intellectual Property India Publishes Patent Application for 'Attenuation Of Cytokine Release Syndrome In Immunotherapy' Filed by Micro Crispr Pvt. Ltd.

MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202522092086 A) filed by Micro Crispr Pvt. Ltd., Vapi, Gujarat, on Sept. 25, for 'attenuation of cytokine release syndrome in immunotherapy.'

Inventor(s) include Bilakhia, Aaman Anjum; Lad, Nilay Mohanlal; Kedaria, Dhaval Ashvinbhai; Panwar, Urvi Hrishiraj; Aich, Jyotirmoi; Vyas, Jitendra Devendra; and Akhtar, Areej.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "The present invention discloses a recombinant nucleic acid molecule encoded at least by an ORF (100, 100a, 100b) to lower a cytokine storm during immunotherapy. The recombinant nucleic a...